ID

35264

Description

Study ID: 100449 Clinical Study ID: 100449 Study Title: Long-term Follow-Up studies at Years 16-20, to evaluate the persistence of immune response of GSK Biologicals’ hepatitis B vaccine in newborns of HBeAg+ and HBsAg+ mothers in comparison with a historical control group Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00240539 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis B Vaccine, Recombinant Trade Name: Engerix-B Study Indication: Hepatitis B

Mots-clés

  1. 25/02/2019 25/02/2019 -
Détendeur de droits

GSK group of companies

Téléchargé le

25 février 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Persistence of immune response of Hepatitis B vaccine in newborns of HBeAg+ and HBsAg+ mothers

Visit 22 - 26 (Follow-Up)

Visit 22 (Year 16) Follow-up
Description

Visit 22 (Year 16) Follow-up

Protocol
Description

Protocol

Type de données

integer

Center
Description

Center

Type de données

integer

Date of visit
Description

Date of visit

Type de données

date

Subject Number
Description

Subject Number

Type de données

integer

INFORMED CONSENT
Description

INFORMED CONSENT

I certify that Informed Consent has been obtained prior to any study procedure.
Description

I certify that Informed Consent has been obtained prior to any study procedure.

Type de données

boolean

Informed Consent Date
Description

InformedConsentDate

Type de données

date

DEMOGRAPHICS
Description

DEMOGRAPHICS

Date of birth:
Description

PREVIOUS STUDY: 103860/272 (EXT: HBV-115) Subject number will be the same as in the previous study.

Type de données

date

Gender
Description

Gender

Type de données

text

Race
Description

Race

Type de données

text

If Other, please specify race
Description

OtherRace

Type de données

text

Height
Description

Height

Type de données

integer

Unités de mesure
  • cm
cm
Weight
Description

Weight

Type de données

float

Unités de mesure
  • kg
kg
LABORATORY TESTS
Description

LABORATORY TESTS

Has a blood sample been taken?
Description

BLOOD SAMPLE

Type de données

boolean

If Yes, please record the date
Description

DateBloodSampleTaken

Type de données

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Description

PreviousHepatitisVaccination

Type de données

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Description

PreviousHistoryOfHipatitisB

Type de données

boolean

If Yes, please specify below
Description

Specify

Type de données

text

Visit 23 (Year 17) Follow-up
Description

Visit 23 (Year 17) Follow-up

Date of visit
Description

VisitDate

Type de données

date

LABORATORY TESTS
Description

LABORATORY TESTS

Has a blood sample been taken?
Description

BLOOD SAMPLE

Type de données

boolean

Please specify the date of blood sample taken
Description

DateBloodSampleTaken

Type de données

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Description

PreviousHepatitisBVaccination

Type de données

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Description

PreviousHistoryOfHepatitisB

Type de données

boolean

If Yes, please specify
Description

Specify

Type de données

text

Visit 24 (Year 18) Follow-up
Description

Visit 24 (Year 18) Follow-up

Date of visit
Description

Visit Date

Type de données

date

LABORATORY TESTS
Description

LABORATORY TESTS

Has a blood sample been taken?
Description

BLOOD SAMPLE

Type de données

boolean

Please specify the date of blood sample taken
Description

DateBloodSampleTaken

Type de données

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Description

PreviousHepatitisBVaccination

Type de données

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Description

PreviousHistoryOfHepatitisB

Type de données

boolean

If Yes, please specify
Description

Specify

Type de données

text

Visit 25 (Year 19) Follow-up
Description

Visit 25 (Year 19) Follow-up

Date of visit
Description

VisitDate

Type de données

date

LABORATORY TESTS
Description

LABORATORY TESTS

Has a blood sample been taken?
Description

BLOOD SAMPLE

Type de données

boolean

Please specify the date of blood sample taken
Description

DateBloodSampleTaken

Type de données

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Description

PreviousHepatitisBVaccination

Type de données

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Description

PreviousHistoryOfHepatitisB

Type de données

boolean

If Yes, please specify
Description

Specify

Type de données

text

Visit 26 (Year 20) Follow-up
Description

Visit 26 (Year 20) Follow-up

Date of visit
Description

VisitDate

Type de données

date

LABORATORY TESTS
Description

LABORATORY TESTS

Has a blood sample been taken?
Description

BLOOD SAMPLE

Type de données

boolean

Please specify the date of blood sample taken
Description

DateBloodSampleTaken

Type de données

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Description

PreviousHepatitisBVaccination

Type de données

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Description

PreviousHistoryOfHepatitisB

Type de données

boolean

If Yes, please specify
Description

Specify

Type de données

text

FOLLOW-UP STUDIES
Description

FOLLOW-UP STUDIES

Would the subject be willing to participate in a follow-up study?
Description

FollowUpStudiesParticipation

Type de données

boolean

If No, please specify
Description

If No, please specify

Type de données

text

If AE or SAE, please specify
Description

AE/SAE

Type de données

text

If Other, please specify
Description

OtherSpecify

Type de données

text

INVESTIGATOR'S SIGNATURE
Description

INVESTIGATOR'S SIGNATURE

I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below.
Description

Investigator'sConfirmationDate

Type de données

date

Investigator's signature
Description

Investigator's signature

Type de données

text

Printed Investigator's name
Description

Printed Investigator's name

Type de données

text

Reason for non participation
Description

Reason for non participation

Protocol number
Description

Protocol number

Type de données

integer

Center
Description

Center

Type de données

integer

Previous study
Description

e.g., 103860 / 272 (EXT:HBV-115)

Type de données

text

Tracking Document
Description

Tracking Document

Previous Subject Number
Description

Previous Subject Number

Type de données

integer

Date of Birth
Description

BirthDate

Type de données

date

Please document reason for non participation
Description

Please document reason for non participation

Type de données

text

In case of death, please specify date
Description

DeathDate

Type de données

date

Date of Contact
Description

Date of Contact

Type de données

date

Investigator's Signature
Description

Investigator's Signature

Investigator name
Description

please PRINT name

Type de données

text

Signature:
Description

Signature:

Type de données

text

Date:
Description

Date:

Type de données

date

Similar models

Visit 22 - 26 (Follow-Up)

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Visit 22 (Year 16) Follow-up
Protocol
Item
Protocol
integer
Center
Item
Center
integer
Date of visit
Item
Date of visit
date
Subject Number
Item
Subject Number
integer
Item Group
INFORMED CONSENT
I certify that Informed Consent has been obtained prior to any study procedure.
Item
I certify that Informed Consent has been obtained prior to any study procedure.
boolean
InformedConsentDate
Item
Informed Consent Date
date
Item Group
DEMOGRAPHICS
Date of birth:
Item
Date of birth:
date
Item
Gender
text
Code List
Gender
CL Item
Male (1)
CL Item
Female (2)
Item
Race
text
Code List
Race
CL Item
Black (1)
CL Item
Arabic/North African (2)
CL Item
White/Caucasian (3)
CL Item
East & South East Asian (4)
CL Item
South Asian (5)
OtherRace
Item
If Other, please specify race
text
Height
Item
Height
integer
Weight
Item
Weight
float
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
If Yes, please record the date
date
PreviousHepatitisVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHipatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify below
text
Item Group
Visit 23 (Year 17) Follow-up
VisitDate
Item
Date of visit
date
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
Please specify the date of blood sample taken
date
PreviousHepatitisBVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHepatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify
text
Item Group
Visit 24 (Year 18) Follow-up
Visit Date
Item
Date of visit
date
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
Please specify the date of blood sample taken
date
PreviousHepatitisBVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHepatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify
text
Item Group
Visit 25 (Year 19) Follow-up
VisitDate
Item
Date of visit
date
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
Please specify the date of blood sample taken
date
PreviousHepatitisBVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHepatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify
text
Item Group
Visit 26 (Year 20) Follow-up
VisitDate
Item
Date of visit
date
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
Please specify the date of blood sample taken
date
PreviousHepatitisBVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHepatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify
text
Item Group
FOLLOW-UP STUDIES
FollowUpStudiesParticipation
Item
Would the subject be willing to participate in a follow-up study?
boolean
Item
If No, please specify
text
Code List
If No, please specify
CL Item
Adverse Events, or Serious Adverse Events (1)
CL Item
Other (2)
AE/SAE
Item
If AE or SAE, please specify
text
OtherSpecify
Item
If Other, please specify
text
Item Group
INVESTIGATOR'S SIGNATURE
Investigator'sConfirmationDate
Item
I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below.
date
Investigator's signature
Item
Investigator's signature
text
Printed Investigator's name
Item
Printed Investigator's name
text
Item Group
Reason for non participation
Protocol number
Item
Protocol number
integer
Center
Item
Center
integer
Previous study
Item
Previous study
text
Item Group
Tracking Document
Previous Subject Number
Item
Previous Subject Number
integer
BirthDate
Item
Date of Birth
date
Item
Please document reason for non participation
text
Code List
Please document reason for non participation
CL Item
Subject not eligible (1)
CL Item
Subject lost to follow-up or not reached (2)
CL Item
Subject eligible but not willing to participate due to adverse events, or serious adverse event (3)
CL Item
Subject eligible but not willing to participate due to other reasons (4)
CL Item
Subject died (5)
DeathDate
Item
In case of death, please specify date
date
Date of Contact
Item
Date of Contact
date
Item Group
Investigator's Signature
Investigator name
Item
Investigator name
text
Signature:
Item
Signature:
text
Date:
Item
Date:
date

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial